2010 discharge: European Medicines Agency (EMA)

PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2010, as part of the 2010 discharge procedure.

Analysis of the accounts of the European Medicines Agency (EMEA).

CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2010 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 129 (2) of the Financial Regulation applicable to the EU's General Budget, including the European Medicines Agency (EMEA).

In 2010, the tasks and budget of this agency were as follows:

• description of the Agency's tasks: the European Medicines Agency, which is located in London, was created by Council Regulation (EEC) No 2309/93, which was replaced by Regulation (EC) No 726/2004 of the European Parliament and of the Council. The Agency operates through a network and coordinates the scientific resources made available by the national authorities in order to ensure the evaluation and supervision of medicinal products for human or veterinary use;
• the Agency's budget for the 2010 financial year: the Agency's 2010 budget amounted to EUR 208.4 million, compared with EUR 194.4 million the previous year. The number of staff employed by the Agency at the end of the year was 698, as compared with 664 the previous year.

The complete version of the Agency's final accounts may be found at the following address: http://www.ema.europa.eu/docs/en_GB/document_library/Report/2011/07/WC500108349.pdf